Recent cannabis use affects the association between baseline immune markers and long-term outcomes in psychosis.
Saved in:
| Title: | Recent cannabis use affects the association between baseline immune markers and long-term outcomes in psychosis. |
|---|---|
| Authors: | Kreis I; Centre for Precision Psychiatry, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. isabel.viola.kreis@nkvts.no.; Section for Clinical Psychosis Research, Department of Research and Innovation, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. isabel.viola.kreis@nkvts.no., Fjelnseth Wold K; Section for Clinical Psychosis Research, Department of Research and Innovation, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Åsbø G; Section for Clinical Psychosis Research, Department of Research and Innovation, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.; Department of Psychology, Faculty of Social Sciences, University of Oslo, Oslo, Norway., Bärthel Flaaten C; Section for Clinical Psychosis Research, Department of Research and Innovation, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway., Engen MJ; Nydalen District Psychiatric Center, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway., Lyngstad SH; Nydalen District Psychiatric Center, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway., Hustad Widing L; Section for Clinical Psychosis Research, Department of Research and Innovation, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.; Department of Child and Adolescent Psychiatry, Division of Mental Health and Substance Use, Diakonhjemmet Hospital, Oslo, Norway., Sheikh MA; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Frogner Werner MC; Division of Clinical Neuroscience, Department of Research and Innovation, Oslo University Hospital, Oslo, Norway., Bakken E; Section for Precision Psychiatry, Department of Research and Innovation, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway., Ueland T; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway., Steen NE; Centre for Precision Psychiatry, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section for Clinical Psychosis Research, Department of Research and Innovation, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.; Department of Psychiatric Research, Division of Mental Health and Substance abuse, Diakonhjemmet Hospital, Oslo, Norway., Melle I; Section for Clinical Psychosis Research, Department of Research and Innovation, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.; Adult Psychiatry Department, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. |
| Source: | Translational psychiatry [Transl Psychiatry] 2025 Aug 14; Vol. 15 (1), pp. 282. Date of Electronic Publication: 2025 Aug 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101562664 Publication Model: Electronic Cited Medium: Internet ISSN: 2158-3188 (Electronic) Linking ISSN: 21583188 NLM ISO Abbreviation: Transl Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2158-3188 |
|---|---|
| DOI: | 10.1038/s41398-025-03498-x |
